Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV-Reference-Cited by-同舟云学术

Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV

Published:2019-10-16 Issue:44 Volume:58 Page:4447-4455
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Gibson Elizabeth G.^ORCID,Oviatt Alexandria A.^ORCID,Cacho Monica¹,Neuman Keir C.²^ORCID,Chan Pan F.³,Osheroff Neil⁴^ORCID

Affiliation:

1. Department of Diseases of the Developing World, GlaxoSmithKline, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain

2. Laboratory of Single Molecule Biophysics, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20982, United States

3. Infectious Diseases Discovery, Medicines Opportunities Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania 19426, United States

4. VA Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States

Funder

U.S. Department of Veterans Affairs

National Heart, Lung, and Blood Institute

American Association of Pharmaceutical Scientists

Pharmaceutical Research and Manufacturers of America Foundation

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Biochemistry